• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 215/08 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom

Patent holdings for IPC class C07D 215/08

Total number of patents in this class: 122

10-year publication summary

9
8
11
7
7
10
8
3
5
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bayer AG
3323
7
Sanofi
4036
6
Conopco, Inc.
4994
4
Sumitomo Chemical Company, Limited
9031
4
Lead Pharma Holding B.V.
20
4
Bristol-myers Squibb Company
4879
3
F. Hoffmann-La Roche AG
7934
3
Merck Sharp & Dohme Corp.
2200
3
Board of Regents, The University of Texas System
5763
3
Cytokinetics, Inc.
273
3
Unilever PLC
3214
2
Unilever N.V.
3121
2
President and Fellows of Harvard College
5964
2
Northwestern University
3374
2
Astex Therapeutics Limited
237
2
Fondazione Istituto Italiano di Tecnologia
578
2
Indiana University Research and Technology Corporation
795
2
Japan Tobacco Inc.
3580
2
Mitsubishi Tanabe Pharma Corporation
579
2
SABIC Global Technologies B.V.
4326
2
Other owners 62